You are here

P&T News

September 22

Patients with impaired liver function receiving too many doses

September 21

GOP takes heavy fire over pre-existing conditions
FDA and some companies dispute findings of report in NEJM
Benefits of opioid addiction treatment outweigh risks of adverse effects
Those in development are at best short-term solutions

September 20

Easier-to-clean Pentax device may help limit bacterial infections

September 19

First once-daily, single-inhaler triple therapy for the disease in the U.S.
Such drugs often block the serotonin that other organs need
Proprietary delivery system deposits proven steroid deep into the nose
Patient deaths related to other combination therapies concern the agency
Detailed procedures aim to protect patients from promising treatment’s toxicities

September 18

Single-dose oral therapy treats leading gynecological infection
Injection is also approved for GEP-NETs
PFS worse with bendamustine and rituximab in new study

September 15

Approval based on totality of evidence from global development program showing Mvasi is highly similar to Genentech’s Avastin
Panel believes GSK’s Shingrix represents an improvement over Merck’s Zostavax
In a clinical trial, the prescription-only adjunct treatment significantly increased patient adherence to abstinence

Pages